Indian equity benchmarks advanced on Thursday, driven by gains in heavyweight financials, although a decline in Tata Motors ...

As much as $135 million in value will be unlocked as stock of five companies eligible for trading as their shareholder ...

Hero MotoCorp, Bajaj Finserv, IndusInd Bank, HDFC Life, NTPC were among major gainers on the Nifty, while losers were Tata ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals ...

Trading volumes of all these stocks were higher than average, as shares allotted to anchor investors ahead of their IPO ...

Corvus Pharmaceuticals has faced volatility due to mixed clinical data and given the current valuation and market ...

ABB India, PB Fintech, Info Edge, and Dr. Agarwal's Eye Hospital are some of the other stocks on analysts' radar.

Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.

The Indian stock markets ended on a strong note on Thursday, with both the Sensex and Nifty closing in the green.The 30-sh ...

As market participants await the onset of the monthly F&O expiry week with the opening bell on March 24, here are a number of ...

IST, the barometer index, the S&P BSE Sensex, slipped 259.73 points or 0.34% to 77,348.12. The Nifty 50 index declined 66.35 points, or 0.28%, to 23,525.60.

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amneal ... drugs once their patents expire. These companies benefit from ...